{"transactions":[{"id":4630915,"issuer":{"id":803,"kind":"organization","name":"QumulusAI, Inc.","symbol":"QMLS"},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T21:25:31.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":8681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares vest on October 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,847 shares to be issued upon vesting and settlement pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates."}],"balance_after":32477,"source":{"system":"sec-edgar","filing":"0001211437-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2084026/000121143726000003/primary_doc.xml","form_type":"4"}},{"id":1610,"issuer":{"id":803,"kind":"organization","name":"QumulusAI, Inc.","symbol":"QMLS"},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-03T12:13:46.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":9583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares vest on October 1, 2026 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,166 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates."}],"balance_after":23796,"source":{"system":"sec-edgar","filing":"0001211437-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2084026/000121143726000002/primary_doc.xml","form_type":"4"}},{"id":1609,"issuer":{"id":803,"kind":"organization","name":"QumulusAI, Inc.","symbol":"QMLS"},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-03T12:13:46.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":9583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares vest with respect to 3,162 shares on October 1, 2026 and with respect to 8.375% of the remaining shares quarterly over 8 quarters commencing January 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI, Inc. through the applicable vesting date."}],"balance_after":14213,"source":{"system":"sec-edgar","filing":"0001211437-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2084026/000121143726000002/primary_doc.xml","form_type":"4"}},{"id":912470,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting CEO"}}],"security":"Common Stock","published_at":"2026-02-11T01:53:30.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 4,071 shares of common stock and (ii) 50,000 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":54071,"source":{"system":"sec-edgar","filing":"0001493152-26-006053","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226006053/ownership.xml","form_type":"4"}},{"id":1165833,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T12:35:38.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":27818,"price":1.45,"value":40336.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73292,"source":{"system":"sec-edgar","filing":"0001641172-25-006118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006118/ownership.xml","form_type":"4"}},{"id":1184155,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:30:22.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":46728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the 45th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 32,363 shares of common stock and (ii) 68,747 unvested restricted stock units."}],"balance_after":101110,"source":{"system":"sec-edgar","filing":"0001641172-25-002391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225002391/ownership.xml","form_type":"4"}},{"id":1365379,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T21:30:23.000Z","date":"2024-11-13","kind":"sale","planned":false,"acquired":false,"shares":2559,"price":3.28,"value":8393.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.36, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 32,363 shares of common stock and (ii) 22,019 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":54382,"source":{"system":"sec-edgar","filing":"0001493152-24-045937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224045937/ownership.xml","form_type":"4"}},{"id":1365378,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T21:30:23.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":14124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 34,922 shares of common stock and (ii) 22,019 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":56941,"source":{"system":"sec-edgar","filing":"0001493152-24-045937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224045937/ownership.xml","form_type":"4"}},{"id":1471006,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:33.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":36016,"price":0.69,"value":24851.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.71, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 282,534 shares of common stock and (ii) 145,622 unvested restricted stock units."}],"balance_after":428156,"source":{"system":"sec-edgar","filing":"0001493152-24-024964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024964/ownership.xml","form_type":"4"}},{"id":1471005,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:25:33.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 318,550 shares of common stock and (ii) 145,622 unvested restricted stock units."}],"balance_after":464172,"source":{"system":"sec-edgar","filing":"0001493152-24-024964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224024964/ownership.xml","form_type":"4"}},{"id":1681781,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T23:30:07.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":66675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of November 12, 2024, a change in control of the Issuer, or the Reporting Person's death or disability. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 229,025 shares of common stock and (ii) 156,200 unvested restricted stock units."}],"balance_after":385225,"source":{"system":"sec-edgar","filing":"0001493152-24-001982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224001982/ownership.xml","form_type":"4"}},{"id":1771655,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T23:01:23.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":89525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 229,025 shares of common stock and (ii) 89,525 unvested restricted stock units."}],"balance_after":318550,"source":{"system":"sec-edgar","filing":"0001493152-23-034936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223034936/ownership.xml","form_type":"4"}},{"id":2108884,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T02:45:18.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":47732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":229025,"source":{"system":"sec-edgar","filing":"0001493152-22-033219","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033219/ownership.xml","form_type":"4"}},{"id":2191165,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T00:36:35.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":85714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of Sonim Technologies, Inc. (the \"Issuer\") or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":181293,"source":{"system":"sec-edgar","filing":"0001493152-22-021818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222021818/ownership.xml","form_type":"4"}},{"id":2511179,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:41:55.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":13953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of  stockholders, a change in control of the Issuer or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":95579,"source":{"system":"sec-edgar","filing":"0000899243-21-044827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321044827/doc4.xml","form_type":"4"}},{"id":2541837,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T21:11:54.000Z","date":"2021-10-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021."}],"balance_after":81626,"source":{"system":"sec-edgar","filing":"0000899243-21-040377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000089924321040377/doc4.xml","form_type":"4"}},{"id":2661555,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":1280,"kind":"person","name":"MULICA MICHAEL C","position":1,"cik":"0001211437","reported_name":"MULICA MICHAEL C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T19:53:59.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":66265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in one installment on the first to occur of the issuer's 2022 annual meeting of stockholders or June 17, 2022."}],"balance_after":66265,"source":{"system":"sec-edgar","filing":"0001211437-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000121143721000002/primary_doc.xml","form_type":"4"}}]}